Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 466 of 1,261

  1. US 10449230

    Polymyxin derived cell penetrating scaffolds

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  2. US 10449207

    Acyclic nucleoside phosphonate diesters

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  3. US 10449210

    Prodrug compounds and their uses

    Ligand Pharmaceuticals Incorporated · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  4. US 10449203

    Tianeptine oxalate salts and polymorphs

    TONIX PHARMA LIMITED · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  5. US 10449182

    Sorafenib derivatives as p21 inhibitors

    The Regents of the University of California · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  6. US 10449178

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  7. US 10449185

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  8. US 10449184

    Pharmaceutical compositions of therapeutically active compounds

    Agios Pharmaceuticals, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  9. US 10449176

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  10. US 10449170

    Compositions for diagnosis and treatment of type 2 diabetes

    The United States of America, as represented by Secretary of the Navy · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  11. US 10449129

    Encapsulates of salicylic acid and polysalicylic acid derivatives

    Biocogent, LLC · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  12. US 10449152

    Drug loaded microspheres for post-operative chronic pain

    Covidien LP · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  13. CA 3096765

    PRODUITS DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN INHIBITEUR D'HISTONE DESACETYLASE (HDAC) ET UN AGONISTE DE TLR7 ET/OU UN AGONISTE DE TLR8 POUR LE TRAITEMENT DU CANCER

    4SC AG [DE] · Granted Oct 17, 2019 · Expires Oct 12, 2039

    granted

  14. WO 2019200238

    COMBINAISONS COMPRENANT UN OLIGONUCLÉOTIDE DE TYPE CPG-C ET UN INHIBITEUR D'HISTONE DÉSACÉTYLASE POUR LE TRAITEMENT DU CANCER

    DYNAVAX TECH CORP [US] · Granted Oct 17, 2019 · Expires Oct 12, 2039

    granted

  15. WO 2019197609

    ANTICORPS DIRIGÉS CONTRE BST1 POUR PRÉVENIR OU TRAITER LE SYNDROME MYÉLODYSPLASIQUE

    BERLIN CHEMIE AG [DE] · Granted Oct 17, 2019 · Expires Oct 12, 2039

    granted

  16. US 10441552

    Anti-microbial composition comprising cannabinoids

    AXIM BIOTECHNOLOGIES. INC. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  17. US 10442852

    Methods and compositions for treatment of symptoms associated with intracranial hemorrhage

    The Board of Regents of the University of Texas System · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  18. US 10442788

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  19. US 10441586

    CRMP2 SUMOylation inhibitors and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  20. US 10444237

    Anti-pancreatic cancer monoclonal antibody and use thereof

    NANJING MARKERLINE BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  21. US 10441645

    MSLN targeting DNA vaccine for cancer immunotherapy

    Vaximm AG · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  22. US 10441614

    Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

    Krystal Biotech, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  23. US 10441607

    Multifunctional linker technology containing an N4 group

    The Board of Regents of the University of Texas System · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

  24. US 10442846

    Hepcidin analogues and uses thereof

    Protagonist Therapeutics, Inc. · Granted Oct 15, 2019 · Expires Oct 10, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.